
Vicef T 250mg/31.25mg Injection
Marketer
Vatican Life Sciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Vicef T 250mg/31.25mg Injection
Cefixime and Sulbactam 250mg/31.25mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. This medication inhibits bacterial proliferation, thereby curbing infection spread. Administration must be strictly under a physician's guidance; consistent adherence to the prescribed schedule is crucial. Complete the full course of treatment, even with symptom improvement; premature cessation may compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms require immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, itching, swelling, respiratory distress). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, proper nutrition, and sufficient hydration are essential for optimal recovery. Your doctor may order tests to monitor the medication's effects.
Primary Ingredients of Vicef T 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vicef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Vicef T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Vicef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Vicef T 250mg/31.25mg Injection:
This medication will be administered by your physician or their designated nurse; please do not attempt self-medication.
How Vicef T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg (Vicef T Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol ingestion alongside Vicef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Vicef T 250mg/31.25mg is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data in humans are scarce.
Breast feedingCAUTION
Administering Vicef T 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Vicef T 250mg/31.25mg Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Vicef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The administration of Vicef T 250mg/31.25mg Injection requires careful consideration in individuals with significant hepatic impairment. A modified dosage of Vicef T 250mg/31.25mg Injection may be necessary. Medical advice is recommended. Altering the dosage of Vicef T 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Vicef T 250mg/31.25mg Injection :
Omitting a scheduled dose of Vicef T 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Vicef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
